Novel Immunotherapy Vaccine Decreases Recurrence in HER2 Positive Breast Cancer Patients
A new breast cancer vaccine candidate, (GP2), provides further evidence
of the potential of immunotherapy in preventing disease recurrence.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news